What Goes Into a China Cosmetic Safety Assessment Dossier

If you've only ever assembled a product information file for the EU or filed a notification with Health Canada, the China dossier will feel like a different animal. It's heavier on toxicology, heavier on efficacy proof, and it expects things that Western regulators mostly take on trust.

The shift in what "safety" means as a filing requirement

In most Western frameworks, a safety assessment is a document your assessor signs off on, built from ingredient data, known toxicology, and use pattern. It lives in your files and gets produced if asked. China's approach treats the safety assessment as a submission requirement in its own right, reviewed as part of getting the product to market, not just kept on hand for an audit. That difference in posture changes how much detail you need and how defensible each conclusion has to be.

The dossier generally needs to establish safety at the level of individual ingredients and at the level of the finished formula, considering the product category, how it's used, and who's likely to use it. For a general moisturizer that's one level of scrutiny. For something marketed at children, or for a product making a specific functional claim, the bar sits higher.

Efficacy evidence: proving the claim, not just making it

This is the part that surprises makers coming from other markets. If your label or marketing says a product brightens skin, reduces the look of fine lines, or provides sun protection, many of these claims require supporting evidence as part of getting the product legally on shelves. It isn't enough that the formula plausibly does what you say. You need documentation that ties the claim to test data or literature that supports it.

This has real implications for how you write your marketing copy before you ever get to the regulatory stage. A vague claim like "hydrating" is generally easier to support than a specific, measurable one like "reduces wrinkle depth by a stated percentage." If you're building a product for the China market, or considering it down the line, it's worth deciding early which claims you actually need to make, because each one you keep is another piece of evidence you'll need to gather and defend.

How this compares to a Western product information file

Element	Typical Western PIF/safety file	China dossier expectation
Ingredient safety data	Compiled by assessor, kept on file	Compiled and generally submitted or reviewable as part of market entry
Efficacy claims	Often supported informally or not required upfront	Frequently need direct supporting evidence tied to the specific claim
Responsible party	Named person or entity, varies by market	Local responsible party requirements, always confirm current rules
Review timing	Often notification-based, product can go to market quickly	Historically involves more structured review, timelines vary by category
New ingredients	Assessed against existing lists	Often subject to separate scrutiny for ingredients new to the market

Treat that table as a general shape, not a checklist you can file against. China's cosmetic regulatory framework has moved through significant changes in recent years, and requirements differ by product category (ordinary versus special-use products, for instance, are often treated quite differently). If China is a real market for you, this is a case where working with someone who tracks that framework specifically, or going straight to the current official guidance, is worth the time before you commit to a formula or a claim.

What a maker outside China can still do to prepare

Even if you're not filing there yet, a few habits pay off if China might ever be on your roadmap:

• Keep raw efficacy data (patch tests, instrumental measurements, consumer perception studies) rather than just conclusions, so you have something to build a dossier from later.
• Separate your ingredient list into components with clean INCI names and CAS numbers now, since that groundwork transfers across every market, not just China.
• Be deliberate about which functional claims you attach to a product. Fewer, well-supported claims travel better internationally than a long list of vague promises.
• Watch for ingredients that are new or unusual in your formula. Novel ingredients tend to draw more scrutiny everywhere, and China is no exception.

For most small and mid-size makers, Canada, the US, and the EU are the markets they're filing in first, and honestly that's plenty to keep organized on its own. Cosmetic Comply currently handles Canadian notifications end to end, matching ingredients to INCI names and CAS numbers and screening them against the Hotlist, with US, EU, and Australian filings on the roadmap. China isn't part of that lineup yet, but the ingredient and CAS groundwork you do for a Cosmetic Comply filing is the same groundwork any China dossier will eventually ask you to produce.